Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

AAUS vs SIGA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SIGA Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 6–2 Matrix Metrics)

SIGA Overall Winner 6-Pillar Tally: AAUS 0 – 6 SIGA Matrix Metrics: AAUS 2 – 6 SIGA

As of Nov 19, 2026, SIGA Technologies Inc. (SIGA) is the stronger overall head-to-head candidate over AAUS (AAUS) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AAUS carries a Unified Composite Score of 47.5/100 (HOLD) at $57.32 (N/M Forward P/E, N/A operating margin), whereas SIGA carries 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin).

  • Technical & Structure Timing Caution: AAUS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AAUS vs SIGA
AAUS US Equity
AAUS
Institutional Equity
$57.32
-1.97% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.99β · 24% Vol
Unified Composite Score
47.5 / 100 HOLD
Tech 38.0 Fund 49.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 32
RSI-14: 32.4 · SMA20: $60.25 · SMA50: $61.27
SIGA NASDAQ Head-to-Head Winner
SIGA Technologies Inc.
Pharmaceutical Preparations
$2.65
-5.36% 1D
Market Cap $187.9M
TTM Revenue $52M
Forward P/E 2.5x
Beta / 30D Vol 0.75β · 65% Vol
Unified Composite Score
47.5 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 69.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $3.02 · SMA50: $3.14

6-Pillar Scorecard Institutional Category Breakdown (AAUS 0 – 6 SIGA)

Columns: Metric · AAUS · SIGA
1. Valuation Multiples SIGA
Forward P/E N/M 2.5x
Trailing P/E N/M N/M
PEG Ratio N/M 3.37x
EV / Revenue N/M 1.4x
2. Growth & Scale SIGA
Revenue Growth (YoY) N/A -49.7%
Earnings Growth (YoY) N/A -65.3%
TTM Revenue (USD) N/A $52M
Market Cap N/A $187.9M
3. Profitability & Quality SIGA
Gross Margin N/A 23.4%
Operating Margin N/A -14.2%
Net Profit Margin N/A 1.3%
Return on Equity (ROE) N/A 0.4%
4. Balance Sheet & Cash Flow SIGA
Cash Generation (TTM) N/A -$12M
Cash Flow Margin N/A -22.1%
Net Cash / Leverage N/A ROE $116M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SIGA
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 81.4% (8th %ile)
Put/Call OI Skew N/A 0.04x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat SIGA
OpEx & R&D Intensity N/A 37.6% of Rev ($20M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AAUS (2) vs SIGA (6)
Institutional Metric AAUS SIGA Criterion Row Edge
Market Capitalization
Scale
N/A $187.9M Larger Scale SIGA
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M 2.5x Lower Multiple SIGA
Revenue Growth (YoY)
Growth
N/A -49.7% Higher Growth SIGA
Operating Margin (TTM)
Profitability
N/A -14.2% Higher Margin SIGA
Net Profit Margin
Profitability
N/A 1.3% Higher Margin SIGA
Return on Equity (ROE)
Capital Efficiency
N/A 0.4% Higher ROE SIGA
52-Week Range Position
Momentum
50% ($51–$64) 3% ($3–$7) Stronger Trend AAUS
Beta / 30D Volatility
Risk Regime
0.99β · 24% Vol 0.75β · 65% Vol Lower Realized Risk AAUS
Unified Institutional Score
Composite Signal
47.5 / 100 (HOLD) 47.5 / 100 (HOLD) Higher Composite Tie
Trailing 12M Revenue (USD)
Operating Scale
N/A $52M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 23.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 3.37x PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$12M ($116M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AAUS +7.06 pp
AAUS: -8.0% · SIGA: -15.06%
3M Horizon AAUS +6.21 pp
AAUS: -6.62% · SIGA: -12.83%
6M Horizon AAUS +40.02 pp
AAUS: -3.72% · SIGA: -43.74%
1Y Horizon AAUS +62.61 pp
AAUS: +7.0% · SIGA: -55.61%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAUS vs SIGA. Trailing 12-month operating profitability (AAUS N/A vs SIGA -14.2%) and valuation multiples (AAUS N/M vs SIGA 2.5x Forward P/E) are benchmarked directly in Pillar 4 below.

AAUS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
SIGA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$52M
Gross Margin23.4%
Op. Margin-14.2%
ROE / Fwd P/E0.4% · 2.5x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AAUS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AAUS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SIGA CONSOLIDATION
33d in phase · OBV DISTRIBUTION
Current IV 81.4%
IV Percentile 8th %ile
Put/Call OI Skew 0.04x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SIGA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AAUS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SIGA Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $187.9M market capitalization and -14.2% operating margin.
OpEx & R&D Reinvestment 37.6% of Rev ($20M)
90D Engineering Disclosures 0 Published

Investor FAQ AAUS vs SIGA Key Questions & Quantitative Answers

As of Nov 19, 2026, SIGA Technologies Inc. (SIGA) is the stronger overall head-to-head candidate over AAUS (AAUS) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AAUS carries a Unified Composite Score of 47.5/100 (HOLD) at $57.32 (N/M Forward P/E, N/A operating margin), whereas SIGA carries 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin). Technical & Structure Timing Caution: AAUS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SIGA leads the Growth & Scale pillar: AAUS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with SIGA at -49.7% YoY revenue growth and -65.3% YoY earnings growth on $52M TTM revenue (23.4% gross margin, -14.2% operating margin). On trailing 12-month operating scale, AAUS generates N/A in USD-normalized revenue versus $52M for SIGA. In operating R&D and SG&A reinvestment, AAUS deploys N/A (0 90-day corporate R&D disclosures) versus 37.6% of Rev ($20M) (0 disclosures) for SIGA.

SIGA screens cheaper on headline valuation multiples. AAUS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SIGA trades at 2.5x Forward P/E, N/M Trailing P/E, 3.37x PEG, and 1.4x EV/Revenue (-22.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AAUS (N/A ROE) versus SIGA (0.4% ROE) capital efficiency.

In options market volatility and institutional positioning, AAUS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.99β · 24% Vol realized risk). By comparison, SIGA carries 81.4% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.75β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.